|
MedChemExpress
ml si3 ![]() Ml Si3, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ml-si3/ML-SI3/pmc11814421-42-43-52 Average 94 stars, based on 1 article reviews
ml si3 - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
ML-SI3 is a potent TRPML channel inhibitor with IC50s of 4.7 µM and 1.7 µM for TRPML1 and TRPML2, respectively.
|
Buy from Supplier |
|
MedChemExpress
1r ![]() 1r, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ml-si3/(1R%2C2R)-ML-SI3/pmc12920607-43-3-5 Average 94 stars, based on 1 article reviews
1r - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
Biozol Diagnostica Vertrieb GmbH
ml-si3 ![]() Ml Si3, supplied by Biozol Diagnostica Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ml-si3/ml+si3/pm39201515-202-20-25 Average 90 stars, based on 1 article reviews
ml-si3 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
MedKoo Inc
ml-si3 ![]() Ml Si3, supplied by MedKoo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ml-si3/ml+si3/pmc09296810-67-0-1 Average 90 stars, based on 1 article reviews
ml-si3 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
(rel)-ML-SI3 is one of the active ingredients of ML-SI3 (HY-139426) (another component is (cis)-ML-SI3) that targets three isoforms of TRPML. (rel)-ML-SI3 is an inhibitor of TRPML1 and TRPML3 (IC50=3.1 μM/28.5 μM), and a potent activator
|
Buy from Supplier |
|
(1S,2S)-ML-SI3(CAT: I040953) is the trans-isomer of ML-SI3 and acts as a selective inhibitor of TRPML channels. The (-)-isomer is a potent inhibitor of TRPML1 and TRPML2, with IC50 values of 1.6 μM and 2.3 μM,
|
Buy from Supplier |
|
(1S,2S)-ML-SI3 is a trans-isomer of ML-SI3 that targets all three isoforms of TRPML. (1S,2S)-ML-SI3 is an activator of TRPML2 and TRPML3 (EC50=2.7 μM/10.8 μM) and a potent inhibitor of TRPML1 (IC50=5.9 μM).
|
Buy from Supplier |
|
(±)-trans-ML-SI3 is an inhibitor of TRPML1 and TRPML3 (IC50 values of 3.1 and 28.5 µM, respectively) and an activator of TRPML2 (EC50 value of 3.3 µM. KEYWORDS: (±)-trans-ML-SI3 | Supplier | TRPML1/3 inhibitor;TRPML2 activator |
|
Buy from Supplier |
|
(1R,2R)-ML-SI3 is a potent inhibitor of both TRPML1 and TRPML2 ( IC 50 values of 1.6 and 2.3 μM) and a weak inhibitor ( IC 50 12.5 μM) of TRPML3Form:SolidIC50& Target:TRPML1 1.6 μM (IC 50
|
Buy from Supplier |
Image Search Results
Journal: Cellular and Molecular Bioengineering
Article Title: Hyperosmotic Stress Promotes the Nuclear Translocation of TFEB in Tubular Epithelial Cells Depending on Intracellular Ca 2+ Signals via TRPML Channels
doi: 10.1007/s12195-024-00839-6
Figure Lengend Snippet: The effects of ML-SI3 on the mannitol-mediated hyperosmotic stress-induced nuclear translocation of TFEB in NRK-52E cells. a Representative fluorescence images of Hoechst 33342 (blue) and TFEB (green) staining of NRK-52E cells cotreated with mannitol (200 mM) and ML-SI3 (1 μM or 10 μM) for 1 h. Scale bar: 25 μm. b A summary of the ratios between the nuclear and cytosolic TFEB fluorescence intensities of NRK-52E cells. The data relating to the 200 mM mannitol alone group are identical to those in Fig. c (at 1 h) and are shown for comparison. Data are presented as box and whisker plots, with average (×), median, IQR, minimum value, and maximum value (200 mM mannitol + 1 μM ML-SI3: n = 29; 200 mM mannitol + 10 μM ML-SI3: n = 20). “n” represents the number of images analyzed. ** P < 0.01 vs. 200 mM mannitol treatment (Dunnett’s test). c Representative fluorescence images of Hoechst 33342 (blue) and NFAT (red) staining of NRK-52E cells cotreated with mannitol (200 mM) and ML-SI3 (1 μM or 10 μM) for 1 h. Scale bar: 25 μm. d A summary of the ratios between the nuclear and cytosolic NFAT fluorescence intensities of NRK-52E cells. Data are presented as box and whisker plots, with average (×), median, IQR, minimum value, and maximum value (200 mM mannitol + 1 μM ML-SI3: n = 28; 200 mM mannitol + 10 μM ML-SI3: n = 30). “n” represents the number of images analyzed. ** P < 0.01 vs. 200 mM mannitol treatment (Dunnett’s test)
Article Snippet: For the inhibitor experiments, cells were pre-treated for 15 minutes with ethylene glycol tetraacetic acid (EGTA, 4 mM; FUJIFILM Wako Pure Chemical), 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA-AM, 50 μM; Tokyo Kasei Kogyo, Tokyo, Japan), FK-506 (10 μM or 50 μM; Cayman Chemical, Ann Arbor, MI),
Techniques: Translocation Assay, Fluorescence, Staining, Comparison, Whisker Assay
Journal: Cellular and Molecular Bioengineering
Article Title: Hyperosmotic Stress Promotes the Nuclear Translocation of TFEB in Tubular Epithelial Cells Depending on Intracellular Ca 2+ Signals via TRPML Channels
doi: 10.1007/s12195-024-00839-6
Figure Lengend Snippet: The effects of ML-SI3 on the mannitol-mediated hyperosmotic stress-induced LC3-II upregulation in NRK-52E cells. a , b NRK-52E cells were treated with 200 mM mannitol or cotreated with ML-SI3 (10 μM) for 0, 1, 2, 4, 8, and 12 h. a Representative blot images of LC3-I and LC3-II in NRK-52E cells treated with 200 mM mannitol alone (top) or cotreated with 10 μM ML-SI3 (bottom), where GAPDH served as the loading control. b Relative LC3-II expression level was calculated by normalizing to the level at 0 h, or with no treatment, and plotted as mean ± SEM (mannitol: n = 3; mannitol + ML-SI3: n = 4). “n” represents the number of independent cultures. ** P < 0.01 vs. 0-h or no treatment (Steel test). # P < 0.05 and ## P < 0.01 vs. 200 mM mannitol treatment (Student’s t -test)
Article Snippet: For the inhibitor experiments, cells were pre-treated for 15 minutes with ethylene glycol tetraacetic acid (EGTA, 4 mM; FUJIFILM Wako Pure Chemical), 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA-AM, 50 μM; Tokyo Kasei Kogyo, Tokyo, Japan), FK-506 (10 μM or 50 μM; Cayman Chemical, Ann Arbor, MI),
Techniques: Control, Expressing
Journal: Scientific Reports
Article Title: Obinutuzumab induces lysosomal destabilization via sphingomyelin-dependent inhibition of TRPML2
doi: 10.1038/s41598-026-38087-5
Figure Lengend Snippet: Lysosomal stress and TRPML inhibition enhance obinutuzumab-mediated direct cell death. ( a ) LMP and DCD were measured in Raji cells treated with hypertonic medium (200 mM sucrose) or hypotonic medium (60% distilled water in complete culture medium) for 2 h in the presence of OBI (Hereafter, the concentration of OBI is 10 μg/ml unless otherwise stated). LMP and DCD were evaluated by LysoTracker Green and propidium iodide (PI) staining. One-way ANOVA with Dunnett’s multiple-comparisons test (vs. control). ( b ) OBI-induced LMP and DCD were assessed in Raji cells co-incubated with increasing concentrations of the TRPML inhibitor (1R,2R)-ML-SI3 (10 µM). In parallel, cells pretreated overnight with the PIKfyve inhibitor Apilimod (50 nM) showed enhanced OBI responses, but this effect was abolished when TRPMLs were simultaneously inhibited. One-way ANOVA with Dunnett’s multiple-comparisons test (vs. control). ( c ) Dose-dependent enhancement of OBI-induced DCD was observed following 2-h co-incubation with a fixed concentration of the (1R,2R)-ML-SI3 (10 µM, over 2 h incubation, this (1R,2R)-ML-SI3 treatment condition was used unless otherwise stated). ( d , e ) Time-dependent enhancement of OBI-induced LMP ( d ) and DCD ( e ) were assessed in TRPMLs-targeting siRNA cell lines. ( f ) Lysosome enlargement and fluorescence intensity were indicated by LT Deep Red staining, then imaged by confocal microscopy. (1R, 2R)-ML-SI3, hypertonic, and hypotonic medium were incubated 2 h. Scale bars in all images represent 5 µM. ( g , h ) Quantification of cathepsin B release induced by OBI and (1R,2R)-ML-SI3 treatment. ( g ) Raji cells were treated with (1R,2R)-ML-SI3, hypertonic medium (200 mM sucrose), or hypotonic medium (60% distilled water in complete medium) for 2 h, and with OBI for 4 h. Cathepsin B releases were visualized by confocal microscopy by immunostaining. ( h ) The summary of the release data shows significant cathepsin B secretion in response to OBI treatment, which was further modulated by (1R,2R)-ML-SI3 and osmotic stress conditions. Data are presented as mean ± SEM. *p < 0.05, ***p < 0.001 compared to obi-treated group.
Article Snippet: For drug treatments, (
Techniques: Inhibition, Concentration Assay, Staining, Control, Incubation, Fluorescence, Confocal Microscopy, Immunostaining
Journal: Frontiers in Cellular Neuroscience
Article Title: Activated Endolysosomal Cation Channel TRPML1 Facilitates Maturation of α-Synuclein-Containing Autophagosomes
doi: 10.3389/fncel.2022.861202
Figure Lengend Snippet: Effect of TRPML1-agonist ML-SA1 and TRPML1-antagonist ML-SI3 on autophagy and α-synuclein particles in human dopaminergic neurons. (A) Example images of LUHMES-derived dopaminergic neurons transduced with α-synuclein-T2A-GFP-lentivirus. Six days after transduction neurons were treated for 24 h either with DMSO or 10 μM ML-SA1. Neurons were further stained against human α-synuclein, lysosomal marker Lamp1 and neuronal marker using MAP2. The scale bar represents 20 μm. (B) Close up of (A) . Closed arrowhead marks a α-synuclein-positive/Lamp1-negative particle, open arrowhead marks a α-synuclein-positive and Lamp1-positive particle, asterisk marks a α-synuclein-negative/Lamp1-positive lysosome. (C) Percentage of Lamp1-positive synuclein particles per neuron. Results of 30 cells per condition. Unpaired t -test depicted with respect to DMSO ( p < 0.001). (D) Representative immunoblot of lysates from transduced LUHMES-derived neurons on day 9, treated with DMSO, ML-SA1 10 μM, or ML-SI3 10 μM for 2 h. Full blot shown in . (E) Quantification of the LC3II band relative to LC3I band in n = 3 independent experiments as in (D) . One-way ANOVA showed no significance ( p = 0.8). (F) Representative immunoblot of lysates from transduced LUHMES-derived neurons on day 9, treated with DMSO, ML-SA1 10 μM or ML-SI3 10 μM for 24 h. Full blot shown in . (G) Quantification of the p62 band relative to beta-Tubulin in n = 3 independent experiments as in (F) . One-way ANOVA showed significance ( p < 0.01). Dunnet’s multiple comparisons test is depicted with respect to DMSO. (H) Quantification of Synuclein load relative to beta-Tubulin in n = 3 independent experiments as in (F) . One-way ANOVA showed no significance ( p = 0.2). ** p < 0.01, *** p < 0.001, non-significant differences are depicted as n.s.
Article Snippet:
Techniques: Derivative Assay, Transduction, Staining, Marker, Western Blot
Journal: Frontiers in Cellular Neuroscience
Article Title: Activated Endolysosomal Cation Channel TRPML1 Facilitates Maturation of α-Synuclein-Containing Autophagosomes
doi: 10.3389/fncel.2022.861202
Figure Lengend Snippet: Effect of TRPML1-agonist ML-SA1 and TRPML1-antagonist ML-SI3 on α-synuclein particles in iPSC-derived mature neurons. (A) Example images of NPC-derived neurons transduced with α-synuclein-T2A-GFP using lentivirus. Twenty-one days after transduction, cells were treated for 24 h either with 20 μM ML-SA1 or DMSO. Cells were further stained against human α-synuclein, lysosomal marker Lamp1 and neuronal marker MAP2. The scale bar represents 20 μm. (B) Close up of (A) . Closed arrowhead marks a α-synuclein-positive/Lamp1-negative particle, open arrowhead marks a α-synuclein-positive and Lamp1-positive particle, asterisk marks a α-synuclein-negative/Lamp1-positive lysosome. (C) Percentage of Lamp1-positive synuclein particles per cell. Results of at least 30 neurons per condition. Unpaired t -test depicted with respect to DMSO ( p = 0.01). (D) Representative immunoblot of lysates from transduced neurons on day 21, treated with DMSO, ML-SA1 10 μM, or ML-SI3 10 μM and additionally DMSO or 100 nM BafA1 for 2 h. Full blot shown in . (E) Quantification of the Synuclein-T2A-dimer band relative to total synuclein load in n = 3 independent experiments as in (D) . One-way ANOVA showed significance ( p = 0.03). Results of Dunnet’s multiple comparisons test are depicted with respect to DMSO ( p = 0.03). (F) Quantification of Synuclein load relative to beta-Tubulin in n = 3 independent experiments as in (D) . Two-way-ANOVA showed significant interaction ( p = 0.03), Sidak’s multiple comparisons test is depicted with respect to DMSO. * p < 0.05, ** p < 0.01, non-significant differences are depicted as n.s.
Article Snippet:
Techniques: Derivative Assay, Transduction, Staining, Marker, Western Blot